RESUMO
OBJECTIVE: To estimate original wild-type BNT162b2 effectiveness against symptomatic Omicron infection among children 5-11 years of age. METHODS: This prospective test-negative, case-control study was conducted in Toledo, southern Brazil, from June 2022 to July 2023. Patients were included if they were aged 5-11 years, sought care for acute respiratory symptoms in the public health system, and were tested for SARS-CoV-2 using reverse transcription polymerase chain reaction. In the primary analysis, we determined the effectiveness of two doses of original wild-type BNT162b2 against symptomatic COVID-19. The reference exposure group was the unvaccinated. RESULTS: A total of 757 children were enrolled; of these, 461 (25 cases; 436 controls) were included in the primary analysis. Mean age was 7.4 years, 49.7 % were female, 34.6 % were obese, and 14.1 % had chronic pulmonary disease. Omicron accounted for 100 % of all identified SARS-CoV-2 variants with BA.5, BQ.1, and XBB.1 accounting for 35.7 %, 21.4 % and 21.4 %, respectively. The adjusted estimate of two-dose vaccine effectiveness against symptomatic Omicron was 3.1 % (95 % CI, -133.7 % to 61.8 %) after a median time between the second dose and the beginning of COVID-19 symptoms of 192.5 days (interquartile range, 99 to 242 days). CONCLUSION: In this study with children 5-11 years of age, a two dose-schedule of original wild-type BNT162b2 was not associated with a significant protection against symptomatic Omicron infection after a median time between the second dose and the beginning of COVID-19 symptoms of 192 days, although the study may have been underpowered to detect a clinically important difference. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov number, NCT05403307 (https://classic. CLINICALTRIALS: gov/ct2/show/NCT05403307).
Assuntos
Vacina BNT162 , COVID-19 , SARS-CoV-2 , Eficácia de Vacinas , Humanos , COVID-19/prevenção & controle , COVID-19/imunologia , COVID-19/epidemiologia , Feminino , Masculino , Vacina BNT162/administração & dosagem , Vacina BNT162/imunologia , SARS-CoV-2/imunologia , SARS-CoV-2/fisiologia , Pré-Escolar , Criança , Estudos Prospectivos , Brasil/epidemiologia , Estudos de Casos e ControlesRESUMO
We aimed to evaluate the fungicidal activity of essential oils (EOs) from Baccharis dracunculifolia (Asteraceae), Baccharis uncinella (Asteraceae), Mentha arvensis (Lamiaceae), Salvia officinalis (Lamiaceae), Melaleuca alternifolia (Myrtaceae), and Cymbopogon nardus (Poaceae) in the in vitro control of mycotoxin-producing strains of Aspergillus niger, Aspergillus nomius, Aspergillus flavus, and Fusarium graminearum. EOs' chemical composition was analyzed by gas chromatography-mass spectrometry, and a total of 19, 21, 18, 20, 17, and 15 compounds were identified in B. dracunculifolia, B. uncinella, S. officinalis, M. arvensis, M. alternifolia, and C. nardus EOs, respectively. Contact and volatilization bioassays were performed, for which M. alternifolia and C. nardus EOs had the greatest fungicidal effect (> 90%). Therefore, these EOs were evaluated for minimum inhibitory concentration, medium inhibitory concentration, and sporulation. Effects from the combined use of EOs were also evaluated. EOs interacted in combination, displaying an additive effect against F. graminearum and A. flavus and an antagonistic effect against the remaining isolates. We conclude that C. nardus EO was effective in the control of storage pathogens and that combined EOs can improve their antifungal effects.
Assuntos
Lamiaceae , Óleos Voláteis , Antifúngicos/farmacologia , Óleos Voláteis/química , Fungos , Aspergillus flavus , Testes de Sensibilidade Microbiana , Óleos de Plantas/farmacologiaRESUMO
After the Coronavirus pandemic, the importance of virus surveillance was highlighted, reinforcing the constant necessity of discussing and updating the methods for collection and diagnoses, including for other respiratory viruses. Although the nasopharyngeal swab is the gold-standard sample for detecting and genotyping SARS-CoV-2 and Influenza viruses, its collection is uncomfortable and requires specialized teams, which can be costly. During the pandemic, non-invasive saliva samples proved to be a suitable alternative for SARS-CoV-2 diagnosis, but for Influenza virus the use of this sample source is not recognized yet. In addition, most SARS-CoV-2 comparisons were conducted before the Omicron variant emerged. Here, we aimed to compare Influenza A and Omicron RT-qPCR analysis of nasopharyngeal swabs and saliva self-collection in paired samples from 663 individuals. We found that both nasopharyngeal swab and saliva collection are efficient for the diagnosis of Omicron (including sub-lineages) and for Influenza A, with high sensitivity and accuracy (>90%). The kappa index is 0.938 for Influenza A and 0.905 for SARS-CoV-2. These results showed excellent agreement between the two samples reinforcing saliva samples as a reliable source for detecting Omicron and highlighting saliva as a valid sample source for Influenza detection, considering this cheaper and more comfortable alternative.
Assuntos
COVID-19 , Influenza Humana , Humanos , Influenza Humana/diagnóstico , Teste para COVID-19 , SARS-CoV-2/genética , Saliva , COVID-19/diagnóstico , Nasofaringe , Manejo de EspécimesRESUMO
Actinobacteria have been drawing attention due to their potential for the development of new pest control products. We hereby assess the effects of Streptomyces isolated from marine and caatinga biomes against Duponchelia fovealis Zeller (Lepidoptera: Crambidae), a pest associated with the strawberry culture at a global scale. To this end, eggs deposited by adults were immersed for 5 s in a bacterial suspension, and the larvae were fed on leaflets placed in glass tubes containing bacterial suspensions. In both treatments, the control was a saline solution. The bioassays demonstrated that the Streptomyces strains were able to cause the death of D. fovealis eggs (≈ 40%) and larvae (≈ 65%) compared to untreated eggs (1.4%) and larvae (2.0%). The crude extract of strain T49 and the chitinase extract of strain T26 affected larval growth when applied directly to the thorax of first-instar larvae (larval-adult lifespan of 65.3 ± 0.5 days and 67.5 ± 0.7 days, respectively; survival of 61.2 ± 1.2%) in relation to the control treatment (larval-adult lifespan of 41.75 ± 0.2 days and survival of 83.7 ± 2.6%). The Streptomyces spp. strains T41, T49, and T50 caused antifeeding activity. Apart from larval mortality, the adults that emerged from the larvae exposed to the extracts presented morphological abnormalities, and the moths' chitin spectra showed clear alterations to the pupa and wings. Our studies show, for the very first time, that Streptomyces isolated from the marine environment and the Caatinga biome are effective at provoking the mortality of D. fovealis and are promising agents for developing new products with biological control properties.